Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study

BMC Infectious Diseases

Volumn 17, Issue 1, 2017, Pages

  Yu, Qing ^a   Jia, Peng ^a   Su, Li ^a   Zhao, Hong ^a   Que, Chengli ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

CMVDNA load; Cytomegalovirus; Pneumocystis jiroveciipneumonia; Prognosis

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; VIRUS DNA; ANTIVIRUS AGENT;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CD4+ T LYMPHOCYTE; CENTRILOBULAR NODULE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DYSPNEA; FEMALE; HUMAN; HYPOXEMIA; INFECTION RISK; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; MORTALITY; NON HUMAN IMMUNODEFICIENCY VIRUS PATIENT; OUTCOME ASSESSMENT; PATIENT; PATIENT CODING; PNEUMOCYSTIS PNEUMONIA; PROGNOSIS; RETROSPECTIVE STUDY; VIRAL RESPIRATORY TRACT INFECTION; X-RAY COMPUTED TOMOGRAPHY; COINFECTION; CYTOMEGALOVIRUS INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; MIDDLE AGED; PATHOGENICITY; PNEUMOCYSTIS CARINII; PNEUMONIA, PNEUMOCYSTIS; RISK FACTOR; TREATMENT OUTCOME; VIROLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; COINFECTION; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GLUCOCORTICOIDS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PNEUMOCYSTIS CARINII; PNEUMONIA, PNEUMOCYSTIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 85020208939     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-017-2492-8     Document Type: Article

References (34)

1. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J med. 2004;350(24):2487-98.
2. Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala M, Dary M, et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2002;21(7):523-31.
3. Pagano L, Fianchi L, Mele L, Girmenia C, Offidani M, Ricci P, et al. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres. Br J Hematol. 2002;117(2):379-86.
4. Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis. 2002;34(8):98-107.
5. Zahar JR, Robin M, Azoulay E, Fieux F, Nitenberg G, Schlemmer B. Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. Clin Infect Dis. 2002;35(8):929-34.
6. Salomon N, Perlman DC. Cytomegalovirus pneumonia. Semin Respir Infect. 1999;14(4):353-8.
7. Jacobson MA, Mills J, Rush J, Peiperl L, Seru V, Mohanty PK, et al. Morbidity and mortality of patients with AIDS and first-episode Pneumocystis carinii pneumonia unaffected by concomitant pulmonary cytomegalovirus infection. Am rev Respir Dis. 1991;144(1):6-9.
8. Miles PR, Baughman RP, Linnemann CC Jr. Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS. Chest. 1990;97(5):1072-6.
9. Bozzette SA, Arcia J, Bartok AE, McGlynn LM, McCutchan JA, Richman DD, et al. Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease. J Infect Dis. 1992;165(1):93-8.
10. Benfield TL, Helweg-Larsen J, Bang D, Junge J, Lundgren JD. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. Chest. 2001;119(3):844-51.
11. Angelici E, Contini C, Sebastiani G, Folgori F, Delia S, Serra P, et al. Cytomegalovirus in bronchoalveolar lavage specimens from patients with AIDS: comparison with antigenaemia and viraemia. J med Microbiol. 1996;45(2):149-52.
12. Freeman RB Jr. The 'indirect' effects of cytomegalovirus infection. Am J Transplant. 2009;9(11):2453-8.
13. Kim T, Moon SM, Sung H, Kim MN, Kim SH, Chio SH, et al. Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection. Scand J Infect Dis. 2012;44(9):670-7.
14. Ewig S, Bauer T, Schneider C, Pickenhain A, Pizzulli L, Loos U, et al. Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur Respir J. 1995;8(9):1548-53.
15. Mansharamani NG, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest. 2000;118(3):704-11.
16. Klech H, Pohl W. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur Respir J. 1989;2(6):561-585.
17. Ho M. Cytomegalovirus. In: Mandell GL, editor. Mandell, Douglas, and Benett's principles and practice of infectious disease (vol 2). 4th ed. New York: Churchill Livingstone; 1995. p. 1351-64.
18. Franquet T, Lee KS, Müller NL. Thin-section CT findings in 32 immunocompromised patients with cytomegalovirus pneumonia who do not have AIDS. AJR am J Roentgenol. 2003;181(4):1059-63.
19. Gasparetto EL, Ono SE, Escuissato D, Marchiori E, Roldan L, Marques HL, et al. Cytomegalovirus pneumonia after bone marrow transplantation: high resolution CT findings. Br J Radiol. 2004;77(921):724-7.
20. Webb WR, Müller NL, Naidich DP, editors. High-resolution CT of the lung. 3th ed. Philadelphia: Lippincott-Raven; 2001. p. 71-96.
21. Boiselle PM, Crans CA Jr, Kaplan MA. The changing face of Pneumocystis carinii pneumonia in AIDS patients. AJR am J Roentgenol. 1999;172(5):1301-9.
22. Kuhlman JE, Kavuru M, Fishman EK, Siegelman SS. Pneumocystis carinii pneumonia: spectrum of parenchymal CT findings. Radiology. 1990;175(3):711-4.
23. La Rosa C, Diamond DJ. The immune response to human CMV. Future Virol. 2012;7(3):279-93.
24. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis. 2002;185(3):272-82.
25. Peres RM, Costa CR, Andrade PD, Bonon SH, Albuquerque DM, de Oliveria C, et al. Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR. BMC Infect Dis. 2010;10:147.
26. Cinel G, Pekcan S, Ozçelik U, Alp A, Yalçin E, Dogru Ersöz D, et al. Cytomegalovirus infection in immunocompetent wheezy infants: the diagnostic value of CMV PCR in bronchoalveolar lavage fluid. J Clin Pharm Ther. 2014;39(4):399-403.
27. Papazian L, Hraiech S, Lehingue S, Roch A, Chiche L, Wiramus S, et al. Cytomegalovirus reactivation in ICU patients. Intensive Care med. 2015;42(1):28-37.
28. Xue Y, Jiang L, Wan WG, Chen YM, Zhang J, Zhang ZC. Cytomegalovirus pneumonia in patients with rheumatic diseases after immunosuppressive therapy: a single center study in China. Chin med J. 2016;129(3):267-73.
29. Madi N, Al-Nakib W, Mustafa AS, Saeed T, Pacsa A, Nampoory MR. Detection and monitoring of cytomegalovirus infection in renal transplant patients by quantitative real-time PCR. Med Princ Pract. 2007;16(4):268-73.
30. Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64(1):87-91.
31. Drew WL. Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Curr Opin Infect Dis. 2007;20(4):408-11.
32. Boeckh M, Stevens-Ayers T, Travi G, Huang ML, Cheng GS, Xie H, et al. Cytomegalovirus (CMV) DNA quantitation in bronchoalveolar lavage fluid from hematopoietic stem cell transplant recipients with CMV pneumonia. J Infect Dis 2017. doi: 10.1093/infdis/jix048. [Epub ahead of print].
33. Zhai WJ, Wei JL, Zhao MF, Wang M, Zhou Z, Liu P, et al. Comparison between CMV quantitative PCR and CMV-pp65 antigen test for detection of CMV infection in allogeneic hematopoietic stem cell transplantation. Zhong Guo Shi Yan Xue ye Xue Za Zhi. 2009;17(6):1522-6.
34. Bauer CC, Jaksch P, Aberle SW, Haber H, Lang G, Klepetko W, et al. Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol. 2007;45(2):324-8.